Product
Supplier
Encyclopedia
Inquiry
Home > Active Pharmaceutical Ingredients > Other Chemical Drugs > Tirzepatide for Sale > Premium-Grade Tirzepatide Sale >99% Pure Limited Time Low Prices
Premium-Grade Tirzepatide Sale >99% Pure  Limited Time Low Prices buy - large image1
Premium-Grade Tirzepatide Sale >99% Pure  Limited Time Low Prices buy - image1
Premium-Grade Tirzepatide Sale >99% Pure  Limited Time Low Prices buy - image2
Premium-Grade Tirzepatide Sale >99% Pure  Limited Time Low Prices buy - image3
Premium-Grade Tirzepatide Sale >99% Pure  Limited Time Low Prices buy - image4
Premium-Grade Tirzepatide Sale >99% Pure  Limited Time Low Prices buy - image5
Premium-Grade Tirzepatide Sale >99% Pure  Limited Time Low Prices buy - image6

Premium-Grade Tirzepatide Sale >99% Pure Limited Time Low Prices

TDS 2101 Inquiries

Unit Price: Get Latest Price
CAS No.:

2023788-19-2

Grade:

Pharmaceutical Grade

Content:

99%

Port:

shenzhen

Brand:

csxj Technology Co., Ltd.

Packaging:

5mg 10mg 15mg 20mg 30mg 50/60mg per vial; 10vials/box

Sample Available:

Yes

Price valid (until):

2025-08-13

Company Type:
Trader
Location:
China
Payment Terms:
TT against copy of documents,D/P,L/C,D/A,O/A,TT against B/L draft before shipment,100% TT in advance
Average Lead Time:
7 days
Qualification:
Main Products:

Semaglutide,Retatrutide

  • Product Description

  • Seller Information

  • Inquiry History

  • Description


    name:mia

    WhatsApp :+852 6589 6356;44 7349 736 496
    Telegram:+44 7349736496


    sales003@chjunxi.com



        Product Name                                          tirzepatide
    CAS 2023788-19-2 
    Storage conditions Store at -20°C
    Form Solid
    purity >99%
    Appearance white power
    function weigt loss
    origin china


    Shop Premium-Grade Tirzepatide Sale >99% Pure  Limited Time Low Prices-Detailed Image 1

    Shop Premium-Grade Tirzepatide Sale >99% Pure  Limited Time Low Prices-Detailed Image 2


    Optimized Product Description:
    Tirzepatide (Development Code: LY3298176) is a novel dual agonist targeting both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. Developed for type 2 diabetes management, this molecule demonstrates clinically validated superiority in glycemic control and weight reduction compared to Dulaglutide monotherapy.

    Key pharmacological characteristics include:
    ✅ Balanced Receptor Affinity: Exhibits higher binding selectivity for GIP receptors over GLP-1 receptors
    ✅ Mechanistic Advantage: Dual-receptor activation delivers significantly enhanced hyperglycemia reduction versus selective GLP-1 agonists
    ✅ Native Action Mimicry: Replicates natural GIP signaling pathways at target receptors
    ✅ Regulatory Status: Approved as adjunct therapy to diet/exercise for improving glycemic control in adults with type 2 diabetes

     Shop Premium-Grade Tirzepatide Sale >99% Pure  Limited Time Low Prices-Detailed Image 3

    Optimized Long-Term Benefits Profile:
     Peptide therapies demonstrate sustained physiological advantages through multi-target mechanisms:

    ✅ Glucose Homeostasis Enhancement

    • Modulates gastric emptying kinetics to prolong nutrient absorption
    • Suppresses hepatic glucose overproduction via gluconeogenesis regulation
    • Potentiates glucose-dependent insulin secretion from pancreatic β-cells
    • Maintains blood glucose homeostasis within physiological range

    ✅ Metabolic Parameter Optimization

    • Reduces postprandial hyperglycemia and fasting insulin/glucose levels
    • Lowers hemoglobin A1c (HbA1c) through chronic glycemic control
    • Decreases serum triglycerides and LDL-derived oxidative stress

    ✅ Adipose Tissue & Appetite Regulation

    • Downregulates appetite signaling pathways, reducing caloric intake
    • Increases leptin sensitivity while decreasing circulating leptin resistance
    • Promotes browning of white adipose tissue (WAT→BAT conversion)

    ✅ Weight Management Efficacy

    • Inhibits weight gain through dual satiety enhancement and lipogenesis modulation
    • Demonstrates dose-dependent weight loss effects in clinical obesity management

    Shop Premium-Grade Tirzepatide Sale >99% Pure  Limited Time Low Prices-Detailed Image 4 Shop Premium-Grade Tirzepatide Sale >99% Pure  Limited Time Low Prices-Detailed Image 5

    Shop Premium-Grade Tirzepatide Sale >99% Pure  Limited Time Low Prices-Detailed Image 6

    Optimized Company Profile

    🌍 Global Market Engagement

    We strategically serve international markets with primary exports to Europe, Americas, Southeast Asia, Middle East, and Africa. Our global distribution network ensures reliable supply chain solutions across 50+ economies.

    🏭 Integrated Quality Ecosystem

    • GMP-Certified Manufacturing: All production lines (solvent distribution → peptide synthesis → purification → isolation) operate under validated GMP protocols
    • Scale Flexibility: Modular production trains enable seamless scaling from R&D batches to commercial volumes (mg to kg+)
    • Purification Infrastructure: Continuously upgraded chromatography/HPLC/UF systems ensure bulk peptide API purity ≥99%

    🔬 Advanced Technical Capabilities

    Capability Area Operational Excellence
    Custom Synthesis Tailor-made peptides & intermediates with >98% HPLC purity
    Quality Assurance Full analytical validation (HPLC-MS, NMR, CD) per ICH Q2(R1)
    Containment Systems Dedicated isolators for potent compound handling

    🤝 Client-Centric Value Proposition

    • Technical Sales Team: PhD-supported specialists providing regulatory/application guidance
    • Quality Commitment: Batch-to-batch consistency guaranteed through QbD principles
    • Strategic Partnership Model: Collaborative development programs for lifecycle management

    ♻️ Sustainable Growth Focus

    Ongoing $20M CAPEX program modernizes facilities to support:
    ✅ Annual peptide production capacity expansion (current: 500kg+)
    ✅ Green chemistry initiatives (e.g., solvent recovery >90%)
    ✅ FDA/EMA-compliant documentation systems

    🌍 Global Market Engagement


    Optimized Company Profile

    Shop Premium-Grade Tirzepatide Sale >99% Pure  Limited Time Low Prices-Detailed Image 7 Shop Premium-Grade Tirzepatide Sale >99% Pure  Limited Time Low Prices-Detailed Image 8


    Introduction to transportation

    We usually use a safe shipping method and do not require you to go through any customs clearance. Free shipping to your address without worrying about any customs issues. We have a professional customs clearance team that 100% guarantees the safe delivery of your package. If anything happens to your package, we promise to send it again for free. Enjoy the second free reissue policy. We can safely ship large parcels of 1000-2000kg/time without any customs issues. Our mission is always to put safety first.

    Shop Premium-Grade Tirzepatide Sale >99% Pure  Limited Time Low Prices-Detailed Image 9

    Shop Premium-Grade Tirzepatide Sale >99% Pure  Limited Time Low Prices-Detailed Image 10

    ECHEMI Editorial Reference

    Tirzepatide (LY3298176) was developed as a dual agonist to both GLP-1 and gastric inhibitory polypeptide (GIP) receptors (Frias et al., 2018). Similar to GLP-1, GIP is an incretin hormone that functions to induce insulin secretion.

    Certificates
    • Premium-Grade Tirzepatide Sale >99% Pure  Limited Time Low Prices Certificates 1 TDS

    Basic Info
    Product Name:

    Tirzepatide

    Other Name:

    LY3298176;

    CAS No.:

    2023788-19-2

    Molecular Formula:

    C225H348N48O68

    Molecular Weight:

    4813

    EC Number:

    200-001-8

    Categories:

    Other Chemical Drugs

    Characteristics
    Appearance:

    White to off-white

    Research
    Class:

    Dual agonist — GIPR, GLP-1R

    Status:

    FDA-approved (Mounjaro / Zepbound)

    Mechanism:

    Dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. A 39-amino-acid modified peptide with a C20 fatty diacid moiety that enables albumin binding for extended half-life (~5 days). Selectively activates both GIPR and GLP-1R signaling pathways.

    EC50 (Human GLP1R):

    0.934 nM

    EC50 (Human GIPR):

    0.0224 nM

    Source:

    Frias JP, et al. N Engl J Med. 2021;385(6):503-515.DOI

    FDA:

    Mounjaro, Zepbound (approved 2022-05-13)

    References
    ChEMBL:

    CHEMBL4297839

    DrugBank:

    DB15171

    KEGG DRUG:

    D11360

    PubChem:

    PubChem

    Disclaimer:

    Tirzepatide is approved as a prescription medicine (Mounjaro, Zepbound) in certain jurisdictions. This listing is for industrial and laboratory research use only. Research-chemical listings on B2B marketplaces are not interchangeable with approved medicines. Confirm CAS, specification, and regulatory pathway with the seller. It is not medical advice, a clinical recommendation, or an approved therapy description.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Semaglutide,Retatrutide

    Location:

    Room 1232-1237, 12th Floor, Yilv Building, No. 255, Xiangzhang Road, Jingwanzi Street, Yuhua District, Changsha City, Hunan Province - 2772

    Payment Terms:

    TT against copy of documents,D/P,L/C,D/A,O/A,TT against B/L draft before shipment,100% TT in advance

    Average lead Time:

    7 days

    Total Annual Revenue:

    Less than $1 million

    Total Employees:

    51-100

    Year of Establishment:

    2023

    Changsha Xjun Technology Co., Ltd.was established in 2023 with strong research and development capabilities and superb synthesis technology, as well as advanced quality control measures.

    With synthetic biology platform technology as the core, it conducts innovative research and development, mainly engaged in the research and development of recombinantly expressed pharmaceutical peptides and proteins. Its products include innovative drugs, APIs and  pharmaceutical.

    At present, our company has realized the industrialization of a variety of biosynthetic peptide products and has received cooperation orders from several well-known foreign pharmaceutical companies.

  • Inquiry History
    2101 Inquiries
    Country Product Purchase Quantity Date Posted
    United States

    2023788-19-2 in unlabeled vials 10, 15 and 30 mg

    10  Feb 14, 2024
    United States

    Peptide drug GLP-1 Agonists Tirzepatide CAS 2023788-19-2 Weight loss 399 Inquiries

    10 MG Apr 3, 2024
    United States

    Tirzepatide Raw Powder Weight Loss Peptides CAS No 2023788-19-2 Tirzepatide Injection Peptides

    2 MT Dec 13, 2025
    Brazil

    2023788-19-2

    20 PCS Sep 12, 2026
    Hongkong, China

    2023788-19-2

    1 KG Aug 13, 2026
    Germany

    2023788-19-2

    1 MG Jun 18, 2026
    United States

    2023788-19-2 Retatrutide

    1 G Sep 22, 2023
    United States

    2023788-19-2 Trizepatide

    10 MT Oct 29, 2023
    United States

    Tirzepatide 2023788-19-2

    Feb 19, 2024
    United States

    Tirzepatide 2023788-19-2

    10 G Oct 31, 2023
    United States

    Trizepatide 2023788-19-2 Raw Material LY3298176 Tirzepatide powder

    Dec 2, 2025
    United States

    Fat Burning Peptides Tirzepatide 10mg/Vial 15mg/Vial Tirzepatide CAS: 2023788-19-2

    1 MT Jan 25, 2024
    United States

    Pharmacy Grade CAS 2023788-19-2 Tirzepatide 99% White powder Tirzepatide

    1 MT Oct 20, 2023
    United States

    Peptide drug GLP-1 Agonists Tirzepatide CAS 2023788-19-2 Weight loss

    2 KG Oct 20, 2023
    United States

    supply Tirzepatide Safe Material Shipping Trizepatide 2023788-19-2 Raw Tirzepatide powder

    10 MG Apr 4, 2024
    Kenya

    Janoshik Test Tirzepatide 99% White powder High Quality Tirzepatide Weight loss CAS 2023788-19-2

    30 MG Dec 26, 2025
    United States

    Ex-factory price tirzepatide T30 10vials 30mg kit cas 2023788-19-2 for weight loss peptide

    10  Dec 30, 2024
    United Kingdom

    Manufacturer supply high quality hot sale lowest price Tirzepatide CAS NO,2023788-19-2 99% powder 2023788-19-2 Claire

    100 G Nov 4, 2023
    Canada

    99.9% Purity GLP-1 Injection Weight Loss Peptides Liraglutide Retatrutide Tirzepatide Semaglutide 5mg 10mg CAS 2023788-19-2

    2 MT Oct 22, 2023
    United Kingdom

    tirzepatide

    10 MG Oct 21, 2025
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.